MannkindLogoStackedPreferd.jpg
Career of Diabetes and Medical Pioneer Al Mann Honored at Boston Gala
June 09, 2015 01:47 ET | MannKind
BOSTON, June 9, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a leading biopharmaceutical company focused on patient experience, acknowledged today that Executive Chairman Alfred Mann...
MannkindLogoStackedPreferd.jpg
MannKind to Present at Upcoming Conferences
May 27, 2015 17:00 ET | MannKind
VALENCIA, Calif., May 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing treatments for diabetes, announced today that it will...
MannkindLogoStackedPreferd.jpg
James S. Shannon Rejoins MannKind's Board of Directors
May 21, 2015 10:30 ET | MannKind
VALENCIA, Calif., May 21, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that James S. Shannon, MD, MRCP (UK) has been elected to the company's Board of Directors after...
MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2015 First Quarter Financial Results
May 07, 2015 18:48 ET | MannKind
VALENCIA, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the first quarter ended March 31, 2015. For the first quarter of 2015, total...
MannkindLogoStackedPreferd.jpg
MannKind to Present at Bank of America Merrill Lynch 2015 Healthcare Conference
May 06, 2015 17:00 ET | MannKind
VALENCIA, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that it...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2015 First Quarter Financial Results Conference Call on May 8, 2015
April 30, 2015 17:00 ET | MannKind
VALENCIA, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2015 first quarter financial results on Thursday, May 7, 2015 and its management will host a...
MannkindLogoStackedPreferd.jpg
MannKind to Manufacture 12 Unit Cartridge Strength of AFREZZA(R) Following FDA Approval
April 27, 2015 09:00 ET | MannKind
VALENCIA, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today announced that it will begin to manufacture a 12 unit cartridge strength of AFREZZA (insulin human)...
MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2014 Fourth Quarter and Full Year Financial Results
February 24, 2015 16:05 ET | MannKind
VALENCIA, Calif., Feb. 24, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2014. For the fourth...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Present at the RBC Capital Markets Global Healthcare Conference
February 18, 2015 21:00 ET | MannKind
VALENCIA, Calif., Feb. 18, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on discovering, developing and commercializing therapeutic products for diabetes, announced today that...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2014 Fourth Quarter and Full Year Financial Results Conference Call on February 24, 2015
February 17, 2015 17:30 ET | MannKind
VALENCIA, Calif., Feb. 17, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) will release its 2014 fourth quarter and full year financial results on Tuesday, February 24, 2015 and its...